ANVS
Price
$3.21
Change
+$0.16 (+5.25%)
Updated
Jun 6 closing price
Capitalization
62.55M
65 days until earnings call
NTLA
Price
$8.09
Change
+$0.51 (+6.73%)
Updated
Jun 6 closing price
Capitalization
837.99M
52 days until earnings call
Interact to see
Advertisement

ANVS vs NTLA

Header iconANVS vs NTLA Comparison
Open Charts ANVS vs NTLABanner chart's image
Annovis Bio
Price$3.21
Change+$0.16 (+5.25%)
Volume$633.88K
Capitalization62.55M
Intellia Therapeutics
Price$8.09
Change+$0.51 (+6.73%)
Volume$7.21M
Capitalization837.99M
ANVS vs NTLA Comparison Chart
Loading...
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ANVS vs. NTLA commentary
Jun 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ANVS is a StrongBuy and NTLA is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 09, 2025
Stock price -- (ANVS: $2.43 vs. NTLA: $9.66)
Brand notoriety: ANVS and NTLA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ANVS: 354% vs. NTLA: 83%
Market capitalization -- ANVS: $62.55M vs. NTLA: $837.99M
ANVS [@Biotechnology] is valued at $62.55M. NTLA’s [@Biotechnology] market capitalization is $837.99M. The market cap for tickers in the [@Biotechnology] industry ranges from $334.5B to $0. The average market capitalization across the [@Biotechnology] industry is $2.25B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ANVS’s FA Score shows that 1 FA rating(s) are green whileNTLA’s FA Score has 1 green FA rating(s).

  • ANVS’s FA Score: 1 green, 4 red.
  • NTLA’s FA Score: 1 green, 4 red.
According to our system of comparison, both ANVS and NTLA are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ANVS’s TA Score shows that 5 TA indicator(s) are bullish while NTLA’s TA Score has 5 bullish TA indicator(s).

  • ANVS’s TA Score: 5 bullish, 4 bearish.
  • NTLA’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, NTLA is a better buy in the short-term than ANVS.

Price Growth

ANVS (@Biotechnology) experienced а +20.90% price change this week, while NTLA (@Biotechnology) price change was +5.00% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.11%. For the same industry, the average monthly price growth was +10.01%, and the average quarterly price growth was -2.16%.

Reported Earning Dates

ANVS is expected to report earnings on Aug 13, 2025.

NTLA is expected to report earnings on Jul 31, 2025.

Industries' Descriptions

@Biotechnology (+4.11% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
NTLA($838M) has a higher market cap than ANVS($62.6M). NTLA YTD gains are higher at: -17.153 vs. ANVS (-51.690). ANVS has higher annual earnings (EBITDA): -26.69M vs. NTLA (-523.98M). NTLA has more cash in the bank: 602M vs. ANVS (10.6M). NTLA has higher revenues than ANVS: NTLA (57.9M) vs ANVS (0).
ANVSNTLAANVS / NTLA
Capitalization62.6M838M7%
EBITDA-26.69M-523.98M5%
Gain YTD-51.690-17.153301%
P/E RatioN/AN/A-
Revenue057.9M-
Total Cash10.6M602M2%
Total DebtN/A210M-
FUNDAMENTALS RATINGS
NTLA: Fundamental Ratings
NTLA
OUTLOOK RATING
1..100
8
VALUATION
overvalued / fair valued / undervalued
1..100
29
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
64
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ANVSNTLA
RSI
ODDS (%)
Bearish Trend 13 days ago
85%
N/A
Stochastic
ODDS (%)
Bearish Trend 13 days ago
90%
Bearish Trend 13 days ago
89%
Momentum
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 13 days ago
78%
MACD
ODDS (%)
N/A
N/A
TrendWeek
ODDS (%)
Bullish Trend 13 days ago
85%
Bearish Trend 13 days ago
88%
TrendMonth
ODDS (%)
Bullish Trend 13 days ago
81%
Bullish Trend 13 days ago
78%
Advances
ODDS (%)
Bullish Trend 13 days ago
83%
Bullish Trend 13 days ago
77%
Declines
ODDS (%)
Bearish Trend about 1 month ago
90%
Bearish Trend 27 days ago
88%
BollingerBands
ODDS (%)
Bearish Trend 13 days ago
88%
Bearish Trend 13 days ago
81%
Aroon
ODDS (%)
Bullish Trend 13 days ago
90%
Bullish Trend 13 days ago
87%
View a ticker or compare two or three
Interact to see
Advertisement
ANVS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
NTLA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
AAPL200.420.21
+0.10%
Apple
SPY587.73-3.42
-0.58%
SPDR® S&P 500® ETF
BTC.X107802.330000-1192.312500
-1.09%
Bitcoin cryptocurrency
TSLA356.90-5.99
-1.65%
Tesla
GME31.21-3.80
-10.85%
GameStop Corp

ANVS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ANVS has been loosely correlated with ADXN. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if ANVS jumps, then ADXN could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ANVS
1D Price
Change %
ANVS100%
+19.12%
ADXN - ANVS
43%
Loosely correlated
N/A
EWTX - ANVS
33%
Poorly correlated
-2.34%
TNYA - ANVS
29%
Poorly correlated
-2.67%
IDYA - ANVS
28%
Poorly correlated
+0.72%
NTLA - ANVS
28%
Poorly correlated
+3.59%
More

NTLA and

Correlation & Price change

A.I.dvisor indicates that over the last year, NTLA has been closely correlated with CRSP. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if NTLA jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NTLA
1D Price
Change %
NTLA100%
+3.59%
CRSP - NTLA
68%
Closely correlated
-0.92%
BEAM - NTLA
66%
Loosely correlated
-0.88%
RXRX - NTLA
61%
Loosely correlated
+0.11%
RCKT - NTLA
61%
Loosely correlated
+6.44%
ABCL - NTLA
58%
Loosely correlated
+3.03%
More